Charity of the week: Citizens United for Research in Epilepsy

CURE works to raise awareness about epilepsy and provides seed funding for pioneering research.

Citizens United for Research in Epilepsy (CureEpilepsy.org) works toward a cure for epilepsy by funding innovative research into the causes of this long-misunderstood yet prevalent neurological disease. One in 26 Americans will develop epilepsy in their lifetime, and about 50,000 epileptics die every year from sudden unexpected death in epilepsy, prolonged seizures, and related accidents. CURE works to raise awareness about epilepsy and provides seed funding for pioneering research that often qualifies for further government monies. Since its founding in 1998, CURE has raised more than $26 million to fund 151 such cutting-edge studies. One now underway aims to better understand and prevent post-traumatic epilepsy, which could affect as many as 100,000 soldiers returning from Afghanistan and Iraq with brain trauma.

Each charity we feature has earned a four-star overall rating from Charity Navigator, which rates not-for-profit organizations on the strength of their finances, their control of administrative and fundraising expenses, and the transparency of their operations. Four stars is the group’s highest rating.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us